Earnings Call · Q3 FY2022·2022-10-27

Q3 22EPS +3.85%·Rev n/aQ2 22EPS -64.29%·Rev n/aQ1 22EPS +77.78%·Rev n/aQ4 21EPS -100.00%*·Rev n/a⚠ consensus missing

NovoCure Ltd NVCR

Ingrid Goldberg — Investor Relations

William Doyle — Executive Chairman

Asaf Danziger — Chief Executive Officer

Ashley Cordova — Chief Financial Officer

+0.2%1d on move date+0.8% vs SPY3d+4.4%5d+5.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NVCR calls or request research access.

More NVCR calls Browse calls Request research access